Quantcast

Latest HLA-DR Stories

2014-07-18 23:04:21

Omixon Holotype HLA is a combination NGS Assay and Software product that provides the most accurate high-resolution, high-throughput HLA genotyping available. Budapest, Hungary & Cambridge, MA (PRWEB) July 18, 2014 Global biotechnology company Omixon, headquartered in Budapest with US offices in Cambridge, MA, announces the launch of Omixon Holotype HLA™ - a combination Assay and Software product that leverages the power of Next Generation Sequencing (NGS), for use on the...

2014-06-04 23:07:57

Omixon and CHOP have used next-generation sequencing tools to significantly advance HLA typing, characterizing whole genes with variations fully phased. Cambridge, MA (PRWEB) June 04, 2014 Global bioinformatics software company Omixon, headquartered in Budapest with US offices in Cambridge, MA, announces an exclusive licensing agreement with The Children’s Hospital of Philadelphia (CHOP) to commercialize a new Next Generation Sequencing (NGS) HLA genotyping assay, for use on the...

2011-07-20 07:03:35

(Ivanhoe Newswire) "“ Avoiding kidney mismatching is beneficial in pediatric kidney transplant patients, however, the likelihood of finding a matching donor must be considered against the wait time for a possible donation, according to this study. "Although avoiding HLA [human leukocyte antigen; cell surface antigens that regulate host cell responses to transplanted cells] antigen mismatching has been shown to benefit long-term graft survival, it has raised concerns about disadvantaging...

2011-07-18 16:24:01

Avoiding HLA-DR mismatching appears to be beneficial in pediatric kidney transplant patients, however the likelihood of finding a matching donor must be considered against the wait time for a possible donation, according to a report in the July issue of Archives of Surgery, one of the JAMA/Archives journals. "Although avoiding HLA [human leukocyte antigen; cell surface antigens that regulate host cell responses to transplanted cells] antigen mismatching has been shown to benefit long-term...

2009-06-02 08:09:04

Recent genetic studies have revealed several new sites of genes that are risk factors for developing rheumatoid arthritis (RA). The strongest association with anti-citrullinated protein antibody (ACPA)-positive RA (ACPAs are autoantibodies detected in RA that are used as a major diagnostic tool) has been found for the HLA-DRB1 gene, and this site seems to play a central role in susceptibility to the disease in Caucasian populations. Previous studies have shown a high increase in the risk of...

2008-08-01 09:01:04

EDMONTON, Aug. 1 /PRNewswire-FirstCall/ -- BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that it has completed patient recruitment in its phase III clinical trial of MBP8298 (dirucotide) for the treatment of secondary progressive MS (SPMS). The trial, named MAESTRO-03, includes approximately 510 patients, and is being conducted at 68 trial sites in the U.S. "We have had great success in recruiting patients into the trial,...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.